Migraine Treatment Gaps: Prescriber Guideline Adherence Lags
- Mar 12
- 1 min read
Research Summary
A new study published in the Journal of Headache and Pain investigates how well prescribers adhere to treatment guidelines when using monoclonal antibodies against Calcitonin Gene-Related Peptide (CGRP) for migraine prevention. The research used a register-based cohort to assess prescriber practices. The study found that only 44% of prescribers fully adhered to the recommended guidelines when prescribing these treatments. This highlights a significant gap between current practices and guideline recommendations. The findings emphasize the need for improved education and adherence to ensure optimal patient outcomes in migraine prophylaxis. This study underscores the importance of aligning clinical practice with established guidelines.
Study Details
👥 Research Team: Nordenmalm S et al.
📚 Published In: J Headache Pain
📅 Publication Date: 2026 Mar 10
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.